Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma

por Huang, Song-Fong, Chong, Sio-Wai, Huang, Chun-Wei, Hsu, Heng-Yuan, Pan, Kuang-Tse, Hung, Chien-Fu, Wu, Tsung-Han, Lee, Chao-Wei, Hsieh, Chia-Hsun, Wang, Ching-Ting, Chai, Pei-Mei, Yu, Ming-Chin
Publicado 2022

Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma

por Su, Chung‐Wei, Teng, Wei, Lin, Po‐Ting, Jeng, Wen‐Juei, Chen, Kuei‐An, Hsieh, Yi‐Chung, Chen, Wei‐Ting, Ho, Ming‐Mo, Hsieh, Chia‐Hsun, Wang, Ching‐Ting, Chai, Pei‐Mei, Lin, Chen‐Chun, Lin, Chun‐Yen, Lin, Shi‐Ming
Publicado 2022

Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolizat...

por Lin, Po-Ting, Teng, Wei, Jeng, Wen-Juei, Chen, Wei-Ting, Hsieh, Yi-Chung, Huang, Chien-Hao, Lui, Kar-Wai, Hung, Chen-Fu, Wang, Ching-Ting, Chai, Pei-Mei, Lin, Chen-Chun, Lin, Chun-Yen, Lin, Shi-Ming, Sheen, I-Shyan
Publicado 2022

Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment

por Chan, Kun-Ming, Lai, Yin, Hung, Hao-Chien, Lee, Jin-Chiao, Cheng, Chih-Hsien, Wang, Yu-Chao, Wu, Tsung-Han, Lee, Chen-Fang, Wu, Ting-Jung, Chou, Hong-Shiue, Wang, Ching-Ting, Chai, Pei-Mei, Lien, Hsin-Yi, Lee, Wei-Chen
Publicado 2023